Issued Patents All Time
Showing 1–20 of 20 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12258563 | Modified oligonucleotides | Darren H. Wakefield, David B. Rozema, Omri GOTTESMAN, David L. Lewis | 2025-03-25 |
| 12188017 | Compositions and methods for inhibiting gene expression of alpha-1 antitrypsin | Christine I. Wooddell, David L. Lewis, Darren H. Wakefield, Steven B. Kanner | 2025-01-07 |
| 11840688 | Compositions and methods for inhibiting gene expression of Hif2alpha | So Wong, David L. Lewis, David B. Rozema, Darren H. Wakefield, Steven B. Kanner +7 more | 2023-12-12 |
| 11590156 | RNAi agents for hepatitis B virus infection | Zhen Li, Rui Zhu, Christine I. Wooddell, Bruce D. Given, Tao Pei +3 more | 2023-02-28 |
| 11534453 | RNAi therapy for hepatitis B virus infection | Christine I. Wooddell, David B. Rozema, David L. Lewis, Darren H. Wakefield | 2022-12-27 |
| 11517584 | RNAi agents for Hepatitis B virus infection | Zhen Li, Rui Zhu, Christine I. Wooddell, Bruce D. Given, Tao Pei +3 more | 2022-12-06 |
| 11384355 | Compositions and methods for inhibiting gene expression of alpha-1 AntiTrypsin | Christine I. Wooddell, David L. Lewis, Darren H. Wakefield, Steven B. Kanner | 2022-07-12 |
| 10927373 | Compositions and methods for inhibiting gene expression of Hif2alpha | So Wong, David L. Lewis, David B. Rozema, Darren H. Wakefield, Steven B. Kanner +7 more | 2021-02-23 |
| 10858658 | Compositions and methods for inhibiting gene expression of factor XII | Steven B. Kanner, David L. Lewis, Darren H. Wakefield | 2020-12-08 |
| 10806750 | RNAi therapy for hepatitis B virus infection | Christine I. Wooddell, David B. Rozema, David L. Lewis, Darren H. Wakefield | 2020-10-20 |
| 10780108 | RNAi agents for Hepatitis B virus infection | Zhen Li, Rui Zhu, Christine I. Wooddell, Bruce D. Given, Tao Pei +3 more | 2020-09-22 |
| 10662427 | Compositions and methods for inhibiting gene expression of LPA | Stacey Melquist, Steven B. Kanner, David B. Rozema, David L. Lewis, Darren H. Wakefield +4 more | 2020-05-26 |
| 10308941 | Compositions and methods for inhibiting gene expression of factor XII | Steven B. Kanner, David L. Lewis, Darren H. Wakefield | 2019-06-04 |
| 10130651 | RNAi Therapy for Hepatitis B Virus Infection | Christine I. Wooddell, David B. Rozema, David L. Lewis, Darren H. Wakefield | 2018-11-20 |
| 10006025 | Compositions and methods for inhibiting gene expression of alpha-1 AntiTrypsin | Christine I. Wooddell, David L. Lewis, Darren H. Wakefield, Steven B. Kanner | 2018-06-26 |
| 9976141 | Compositions and methods for inhibiting gene expression of Hif2alpha | So Wong, David L. Lewis, David B. Rozema, Darren H. Wakefield, Steven B. Kanner +7 more | 2018-05-22 |
| 9932586 | Compositions and methods for inhibiting gene expression of LPA | Stacey Melquist, Steven B. Kanner, David B. Rozema, David L. Lewis, Darren H. Wakefield +4 more | 2018-04-03 |
| 9803205 | Compositions and methods for inhibiting gene expression of factor XII | Steven B. Kanner, David L. Lewis, Darren H. Wakefield | 2017-10-31 |
| 9452221 | Poly(acrylate) polymers for in vivo nucleic acid delivery | Darren H. Wakefield, Nicholas A. A. Rossi, David B. Rozema, Anthony L. Perillo-Nicholas | 2016-09-27 |
| 8933047 | Poly(acrylate) polymers for in vivo nucleic acid delivery | Darren H. Wakefield, David B. Rozema, Nicholas A. A. Rossi, Anthony L. Perillo-Nicholas | 2015-01-13 |